Rituximab and Ibrutinib (RI) versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as Initial Therapy for Waldenström’s Macroglobulinaemia (RAINBOW)
Is ibrutinib and rituximab a more effective first-line treatment than the current standard first-line treatment for people with WM?
